News
SkyWater Technology, Inc. (SKYT) Is a Trending Stock: Facts to Know Before Betting on It
SkyWater Technology, Inc. (SKYT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance
The Zacks Rank Explained: How to Find Strong Buy Finance Stocks
Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck.
But how do you find the right
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up
CVS Health Corporation CVS posted third-quarter 2025 adjusted earnings per share (EPS) of $1.60, up 46.8% year over year. The metric topped the Zacks Consensus Estimate by 17.65%. The adjusted EPS
UnitedHealth Lifts EPS Outlook Despite Mixed Q3 Results: ETFs in Focus
Shares of UnitedHealth Group Incorporated (UNH) ticked up 0.5% during the last trading session at the bourses, after it reported better-than-expected third-quarter 2025 earnings but missed the
GE HealthCare Q3 Earnings and Revenues Beat Estimates, Net Margin Falls
GE HealthCare GEHC reported third-quarter 2025 adjusted earnings per share (EPS) of $1.07, which beat the Zacks Consensus Estimate of $1.05 by 1.9%. However, the bottom line declined 6.1% year over
Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?
Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report third-quarter 2025 results on Oct. 30, after market close. The Zacks Consensus Estimate for sales and earnings is pegged at $7.46
Edison International Q3 Earnings Top Estimates, Revenues Increase Y/Y
Edison International EIX reported third-quarter 2025 adjusted earnings of $2.34 per share, which surpassed the Zacks Consensus Estimate of $2.16 by 8.3%. The bottom line also increased 55% from
TEM vs. EXAS: Which Genomics Player Offers Greater Upside?
Per multiple sources, the integration of genomics into cancer care has transformed treatment approaches, moving away from uniform therapies to precision medicine, where clinical decisions are
Logitech's Q2 Earnings Surpass Estimates, Revenues Rise Y/Y
Logitech International S.A. (LOGI) reported second-quarter fiscal 2026 non-GAAP earnings of $1.45 per share, which beat the Zacks Consensus Estimate by 18.9%. Moreover, the bottom line increased 21%
TTD's Global Growth Surges: Can it Outpace the U.S. Expansion?
The Trade Desk, Inc. TTD is showing accelerating global momentum as international revenue growth outpaces its U.S. performance, underscoring the company’s success in expanding its footprint beyond
4 High-Earnings Yield Value Picks Ahead of Potential Fed Rate Cut
Major U.S. stock market indices notched record highs yesterday as investors await the Federal Reserve’s policy decision. The Dow, the S&P 500 and the Nasdaq all hit fresh highs, with the S&P 500
Can Lam Research Sustain $5B-Plus Revenue Streak on Foundry Strength?
Lam Research Corporation LRCX recently reported record first-quarter fiscal 2026 revenues of $5.32 billion, marking the third straight quarter of $5 billion-plus sales. The first-quarter top line
These 2 Consumer Discretionary Stocks Could Beat Earnings: Why They Should Be on Your Radar
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
How to Boost Your Portfolio with Top Computer and Technology Stocks Set to Beat Earnings
Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Kohl's (KSS)
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Boeing (BA) Reports Q3 Loss, Tops Revenue Estimates
Boeing (BA) came out with a quarterly loss of $7.47 per share versus the Zacks Consensus Estimate of a loss of $3.85. This compares to a loss of $10.44 per share a year ago. These figures are
How to Boost Your Portfolio with Top Oils and Energy Stocks Set to Beat Earnings
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
We know
Verano Holdings Corp. (VRNOF) Reports Q3 Loss, Lags Revenue Estimates
Verano Holdings Corp. (VRNOF) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.12 per share a year ago. These
Enova International (ENVA) Shows Fast-paced Momentum But Is Still a Bargain Stock
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Here's Why Momentum in MDxHealth SA (MDXH) Should Keep going
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the
These 2 Construction Stocks Could Beat Earnings: Why They Should Be on Your Radar
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Why Fast-paced Mover Grupo Televisa (TV) Is a Great Choice for Value Investors
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks


